LSD (Lysergic acid diethylamide)

Buy LSD (Lysergic acid diethylamide) online | LSD (Lysergic acid diethylamide) for sale

LSD (Lysergic acid diethylamide) – often known as LSD or acid – is a type of hallucinogenic drug classed under the family of psychedelics. Though there is no conclusive evidence to support that they are addictive or cause long-term harms to mental health, LSD and many psychedelic drugs were declared illegal under the United Nations Convention on Psychotropic Substances of 1971. In the United States, it is classified as a Schedule I drug, the most serious category restricted for substances with “no currently accepted medical use and a high potential for abuse.” buy Shrooms bar near me

Recent research might be turning this around, with a wave of studies resulting in findings so intriguing that government departments are giving the go-ahead for more scientific studies to be done to find out whether psychedelics like LSD can be beneficial. shrooms for sale the story for LSD started decades ago, in the 1930s, when Swiss chemist Albert Hoffman synthesised the acid to create a treatment for bleeding disorders and accidentally absorbed a dose of it during his research. Hoffman quickly became curious about the feelings of euphoria, and wrote about his experience to the scientific community. Soon, researchers all over the world began experimenting with LSD, as well as other plant-based hallucinogens such as psilocybin, derived from mushrooms and mescaline, found in the peyote cactus. buy acid online

Buy drugs without prescriptions. Though the scientific community began nurturing their findings about psychedelics and LSD as a form of treatment for various issues such as alcohol addiction and anxiety disorders, this research was quickly cut short by the negative publicity centred on the side-effects of LSD – which had become common for recreational use – and eventually led to the outlaw of psychedelic substances.

Lsd drug for sale Fast-forward a couple of decades, scientists began exploring the healing potential of psychedelics again using micro-dosages of the drug. In 2008, the Multidisciplinary Association for Psychedelic Studies (MAPS) received approval from the FDA to study LSD-assisted psychotherapy for end-of-life anxiety. The study found “positive trends” to help patients reduce anxiety after 2 sessions administered under the guidance of a certified psychotherapist.

In 2015, a large-scale study involving over 130,000 participants found no link between the use of psychedelics such as LSD, psilocybin or mescaline and mental health damage, though a small percentage in other studies did report negative experiences.